Oxozep 150mg Tablet DT
By Oxozep
Rx
10 Tablet DT in a Strip

Composition
Oxcarbazepine(150mg)

Manufacturer - Lifecare Neuro Products Ltd
70/1 Dharampur, Sai Road, Near Export Promotion Zone Phase-II, Baddi - 173205, (Distt. Solan) Himachal Pradesh (India).

Expires on or after
July, 2026

liver
When taking Oxozep 150mg Tablet DT, it's important to be cautious if you have severe liver disease. In such cases, a dose adjustment may be necessary, so it's advisable to consult your doctor before starting or continuing with this medication. However, for patients with mild to moderate liver disease, dose adjustment is generally not required. It's always essential to prioritize your liver health, so ensure to discuss any existing liver conditions with your healthcare provider before using Oxozep 150mg Tablet DT.

kidney
Oxozep 150mg Tablet DT requires caution in patients with kidney disease. Adjustment of dosage may be necessary. Consult your doctor for guidance.

alcohol
When taking Oxozep 150mg Tablet DT, be cautious when consuming alcohol as it can lead to increased drowsiness.

driving
Oxozep 150mg Tablet DT may make you feel sleepy, dizzy, or cause blurred vision and lack of muscle coordination, especially when starting treatment or increasing the dose. This may affect your driving ability.

pregnancy
Oxozep 150mg Tablet DT may not be safe to use during pregnancy. Limited human studies suggest it may harm the developing baby. Your doctor will evaluate the benefits and risks before prescribing. Consult your doctor for advice.

breastfeeding
Caution is advised when breastfeeding while using Oxozep 150mg Tablet DT. Limited data indicates potential harm to the baby due to drug transfer through breastmilk. Watch for signs like excessive sleepiness and weight gain in the baby.
Habit Forming | No |
Chemical Class | Iminostilbene Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Sodium channel modulators (AED) |
₹55
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024